牛皮关节炎的新兴生物疗法:系统性审查
Saman Firdous1, Hamza Amjad, Muhammad Umair Choudhary
1Department of Medicine, Ibn e Seena Hospital, Kabul, Afghanistan.
Medicine
|November 5, 2025
概括
针对IL-17和IL-23通路的新兴生物药物显示在牛皮关节炎 (PsA) 管理中具有很高的疗效. 这些先进的疗法提供了较好的安全性和更好的结果,与传统的治疗PsA.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 牛皮关节炎 (PsA) 是一种慢性炎症性疾病,影响关节和皮肤.
- 目前的生物修饰性抗风湿药物 (bDMARDs),像TNF抑制剂一样,对一些患者有局限性.
- 针对IL-17,IL-23和JAK通路的较新的生物药物正在为PsA开发.
研究的目的:
- 评估新兴生物药物治疗牛皮关节炎 (PsA) 的疗效和安全性.
- 为了比较新的生物疗法与PsA的现有治疗方法.
主要方法:
- 从2000年到2024年12月对随机对照试验,队列研究和临床试验进行系统审查.
- 包括的研究评估了bDMARDs和针对性合成DMARDs (tsDMARDs) 对PSA的疗效 (例如ACR反应) 和安全性.
- 排除了对非药物治疗或无关节炎的牛皮的研究.
主要成果:
- 审查了20项涉及77,124名参与者的研究.
- IL-17和IL-23抑制剂在PsA的关节和皮肤症状方面表现出高的疗效.
- 新兴药物如比梅奇祖马布显示出更高的疗效;与传统的DMARD相比,生物药物具有有利的安全性.
结论:
- 新兴的生物药物显著改善了PsA管理,而不是传统的DMARDs.
- IL-17和IL-23抑制剂,以及像比梅奇祖马布这样的药物,对于对TNF抑制剂无反应的患者来说是有前途的.
- 个性化治疗策略对于优化PsA结果至关重要,需要进行持续的研究以获得长期数据.
相关概念视频
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
476
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
476
Inflammatory Bowel Disease IV: Pharmacological Management
463
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
463
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
475
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
475
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
Rheumatic Heart Disease III: Medical Management
277
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
277


